Trial Profile
Valsartan vs non-RAAS treatment: effect on autoregulation of cerebral blood flow in isolated systolic hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Dec 2012
Price :
$35
*
At a glance
- Drugs Valsartan (Primary) ; Antihypertensives
- Indications Isolated systolic hypertension
- Focus Pharmacodynamics
- 31 Dec 2012 New trial record